Explore this weekend's OTT releases across Malayalam, Tamil, and Telugu. Thrillers, action, and dramas, including Kishkindha ...
MELD’s market cap is at $2.3 million. Revuto (REVU) is up 27.9% today and shows the potential for a skyrocketing week. Last ...
The Food and Drug Administration approved on Friday a new drug developed by Syndax Pharmaceuticals to treat patients with a ...
The US Food and Drug Administration has approved revumenib (Revuforj — Syndax Pharmaceuticals) for relapsed or refractory ...
Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Syndax Pharmaceuticals (SNDX – Research Report). The associated ...
BTIG analyst Justin Zelin has reiterated their bullish stance on SNDX stock, giving a Buy rating on November 15.Don't Miss our Black Friday ...
Revuforj is approved for relapsed or refractory acute leukemia with KMT2A translocation in patients aged 1 year and older. The AUGMENT-101 trial showed a 21.2% complete remission rate with a median ...
The streaming platforms are gearing up for a big week with several highly anticipated releases. Here are the must-watch ...
A special CBI court granted bail to four CGST officers in a ₹50 lakh bribery case, marking the release of all accused involved.
A CBI court acquitted Jayant Mule and Santosh Bhosale of murder charges in the 2005 killing of businessman Sanjay Gupta, citing insufficient evidence.